Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells
PaperCitations, authors & open-access status
The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 106 citations, 2018 year and gold oa status.
106
Citations
2018
Year
gold
OA Status